Search Results
Mar 03, 2026, 10:15 ET Interlune and Astrolab Collaborate on Technology for Harvesting Resources and Building Infrastructure on the Moon
Research Lab (IRL) develops and tests highly specialized simulants of Moon dirt, or regolith, and is partially funded by the Texas Space Commission (TSC). Testing with simulated lunar regolith supports the development of technology and equipment that can operate effectively in the harsh lunar environment.This
More news about: Interlune
Feb 24, 2026, 09:00 ET SONiC Foundation Welcomes Upscale AI as a Premier Member to Advance Open AI Networking Infrastructure
Santhosh K Thodupunoori on the Technical Steering Committee (TSC).Upscale AI joins existing SONiC Foundation Premier member organizations, including Alibaba, Arista Networks, Broadcom, Cisco, Dell Technologies,
More news about: SONiC
Jan 21, 2026, 10:12 ET Improving Academic Pathways: Workcred Releases Resources for Community Colleges
Labor MarketsThrough a Greater Texas Foundation grant, Workcred collaborated with Houston City College (HCC) and Texas Southmost College (TSC) to align credential pathways to match local labor market needs. Each college is helping students complete their programs, earn valuable postsecondary
More news about: Workcred
Jan 14, 2026, 09:57 ET 113 Epilepsy Organizations Unite to Express Concerns about Leadership Change at the National Institute of Neurological Disorders and Stroke
FoundationThe Cute Syndrome FoundationThe Gould Syndrome FoundationThe LCC FoundationThe Sturge-Weber FoundationTSC AllianceWhat the Ef?! PodcastYellow for Yiannis IRF2BPL-NEDAMSS FoundationYWHAG Research FoundationZTTK SON-Shine
More news about: Epilepsy Foundation
Jan 12, 2026, 12:00 ET CAMARA Charts a Path for Network-Aware AI Applications with MCP
every day, yet they operate disconnected from network capabilities - intelligence, control, and real-time source of truth," said Herbert Damker, CAMARA TSC Chair and Lead Architect, Infrastructure Cloud at Deutsche Telekom. "CAMARA and MCP bring AI and network infrastructure into concert, securely and consistently
More news about: CAMARA Project
Jan 09, 2026, 07:30 ET GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder
including seizures, behavioral manifestations, and functional outcomes. Radiprodil is also being assessed for the treatment of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) type II, two disorders associated with NMDA receptor overexpression. The Astroscape trial (ClinicalTrials.gov identifier:
More news about: GRIN Therapeutics Inc.
Jan 06, 2026, 10:44 ET Forced Air Warming Market expected to generate a revenue of USD 2,580.89 Million by 2032, globally, at 6.81% CAGR: Verified Market Research®
valuable insight with an emphasis on the global market. The major players in the market are 3M, Stryker, Medtronic, ICU Medical Inc., Gentherm, TSC Life, Inspiration Healthcare Group PLC, Augustine Surgical Inc., MOECK & MOECK GmbH, Infinium Medical Inc.Forced Air Warming Market
More news about: Verified Market Research
Dec 19, 2025, 07:55 ET Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
data from its ALLOHA Phase 1 trial showing TSC-101 continued to demonstrate favorable relapse-free survival (HR=0.50) and overall survival (HR=0.61) in patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation. All three TSC-101-treated patients who reached two-year
More news about: Equity Insider
Dec 16, 2025, 08:00 ET TSC Alliance Endowment Fund Invests in Aeovian Pharmaceuticals to Advance Development of an mTORC1 Selective Inhibitor for Tuberous Sclerosis Complex
organization."In 2018, the TSC Alliance partnered with Aeovian Pharmaceuticals by co-funding research through the TSC Preclinical Consortium. This marked a significant step towards the development of innovative mTORC1-specific inhibitors for TSC, particularly in addressing TSC-associated epilepsy. mTORC1
More news about: TSC Alliance
Dec 05, 2025, 09:00 ET Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting
adjunctive Epidiolex treatment in participants with tuberous sclerosis complex (TSC)-associated seizures. Notably, the prespecified 6-month intermediate analysis of EpiCom demonstrated promising reductions in the TSC–Associated Neuropsychiatric Disorders Self-Report Quantified Checklist (TAND-SQ) and
More news about: Jazz Pharmaceuticals plc
Dec 04, 2025, 12:20 ET Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
pivotal trial design for TSC-101 following a productive end of Phase 1 meeting, with the agency approving a study design that mirrors the current ALLOHA Phase 1 trial using a biologically-assigned
More news about: USA News Group
Dec 03, 2025, 07:00 ET GRIN Therapeutics to Present on Global Phase 3 Beeline Clinical Trial of Radiprodil at American Epilepsy Society Annual Meeting
including seizures, behavioral abnormalities and functional outcomes. Radiprodil is also being developed for the treatment of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) type II, two disorders associated with NMDA receptor overexpression. The Astroscape trial (ClinicalTrials.gov identifier:
More news about: GRIN Therapeutics Inc.
Dec 02, 2025, 07:01 ET Iridium Awarded 5-Year System Infrastructure Transformation and Hybridization Contract Worth Up to $85.8 Million
refreshes, lifecycle upgrades, and security enhancements to the Enhanced Mobile Satellite Services (EMSS) Service Center, Technical Support Center (TSC), and Defense Ground Station (DGS). SITH is a follow-on contract to the
More news about: Iridium Communications Inc.
Dec 02, 2025, 07:01 ET Iridium Awarded 5-Year System Infrastructure Transformation and Hybridization Contract Worth Up to $85.8 Million
refreshes, lifecycle upgrades, and security enhancements to the Enhanced Mobile Satellite Services (EMSS) Service Center, Technical Support Center (TSC), and Defense Ground Station (DGS). SITH is a follow-on contract to the
More news about: Iridium Communications Inc.
Dec 01, 2025, 06:55 ET Epicutis® Lipid Shield SPF 30 Achieves EWG Verified® Status
Shield SPF 30 is all of that and more."The First Zinc Oxide SPF with TSC: Protection + RepairLipid Shield is the first and only SPF to harness the power of TSC, a biotech-developed active shown to calm visible redness, protect collagen integrity, and support
More news about: Epicutis Skincare
Nov 25, 2025, 08:00 ET Eleventh Annual Infantile Spasms Awareness Week Scheduled for December 1-7
message that infantile spasms are a medical emergency requiring swift diagnosis and treatment," said Kari Luther Rosbeck, President & CEO of the TSC Alliance®. "And while we have made progress educating parents and physicians through Infantile Spasms Awareness Week, we know there are still
More news about: TSC Alliance
Nov 21, 2025, 12:39 ET Hackensack Meridian John Theurer Cancer Center Unveils Research at the 67th American Society of Hematology Annual Meeting
prediction of response and relapse to venetoclax plus hypomethylating agent based therapy in Acute Myeloid Leukemia (ABSTRACT 25-14588) TSC-101 eliminates recipient hematopoietic cells and demonstrates potential for improved relapse-free survival in patients with AML, ALL, or MDS undergoing
More news about: Hackensack Meridian John Theurer Cancer Center
Nov 13, 2025, 07:00 ET Neurvati Neurosciences Appoints Carlos Martin as Chief Commercial Officer
including seizures, behavioral abnormalities and functional outcomes. Radiprodil is also being developed for the treatment of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) type II, two disorders associated with NMDA receptor overexpression. The Astroscape trial (ClinicalTrials.gov identifier:
More news about: Neurvati Neurosciences
Nov 12, 2025, 07:05 ET Epicutis Expands Global Footprint With New Offices in Sydney and Kyoto
indices in the world, Australia and New Zealand represent a key market for preventive, barrier-supportive skincare. Epicutis' proprietary molecules - TSC, Hyvia®, and DSD - offer scientifically validated protection against oxidative stress, inflammation, and environmental damage, aligning perfectly with
More news about: Epicutis Skincare
Nov 10, 2025, 09:16 ET LPG® America and Epicutis® Partner to Redefine Professional Education with an Exclusive Webinar on Reactive Skin
fibroblasts, encourages collagen and elastin synthesis, enhances microcirculation, and promotes lymphatic flow. When paired with Epicutis®' patented TSC and HYVIA® actives—known for calming inflammation and reinforcing the skin barrier—the result is a comprehensive, science-backed approach to managing
More news about: LPG America
Nov 05, 2025, 08:00 ET DataDasher and Orion Announce Strategic Collaboration to Deliver a Next-Generation AI Workflow for Financial Advisors
Assets include assets managed on a discretionary and non-discretionary basis by Orion Portfolio Solutions, LLC ("OPS") and TownSquare Capital, LLC ("TSC") on their proprietary platforms, assets in proprietary and third-party models made available through OPS's Communities platform, and assets in OPS's
More news about: DataDasher AI
Oct 13, 2025, 12:00 ET SONiC Foundation Accelerates Ecosystem Growth and Global Adoption as the Leading Open Source NOS Optimized for Enterprise AI Workloads
will bring together maintainers, contributors, and technical leaders for deeper collaboration through working group meetings, technical deep dives, and TSC discussions on SONiC's next-phase innovations and roadmap priorities. View the
More news about: SONiC
Sep 24, 2025, 08:40 ET TSC Life Receives FDA 510(K) Clearance for Fluido® AirGuard System, a Moderate to High Flow Blood and IV Fluid Warming Solution for the Prevention of Hypothermia
cost-efficiency," added Duffie. In early 2025, TSC Life transitioned from relying on Stryker to distribute its Mistral-Air® portfolio to building its own direct commercial team in the U.S. market. Paraic Curtis, CEO of TSC Life, commented, "Moving to a direct commercial
More news about: TSC Life